Depression and Suicidal Behavior in Acne Patients Treated With Isotretinoin: A Systematic Review

Seminars in Cutaneous Medicine and Surgery

Volumn 26, Issue 4, 2007, Pages 210-220

  Marqueling, Ann L ^a   Zane, Lee T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ISOTRETINOIN;

ACNE VULGARIS; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG SAFETY; HAMILTON SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LOW DRUG DOSE; PROFILE OF MOOD STATES; RISK FACTOR; SEX DIFFERENCE; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ACNEIFORM ERUPTIONS; CAUSALITY; DEPRESSION; HUMANS; ISOTRETINOIN; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS; SUICIDE;

EID: 41449085961     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2008.03.005     Document Type: Article

References (53)

1. Enders S.J., and Enders J.M. Isotretinoin and psychiatric illness in adolescents and young adults. Ann Pharmacother 37 (2003) 1124-1127
2. Cunliffe W.J., Van De Kerkhof P.C.M., Caputo R., et al. Roaccutane treatment guidelines: Results of an international survey. Dermatology 194 (1997) 351-357
3. Stupak B. Accutane. http://www.house.gov/stupak/accutane.htm ; Internet; accessed April 29, 2005
4. Weiss M. SUICIDE WATCH. Did a powerful acne drug play a role in a Palo Alto 14-year-old's killing himself? (2003) in San Francisco Chronicle Magazine
5. Hull P.R., and D'Arcy C. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol 4 (2003) 493-505
6. O'Donnell J. Overview of existing research and information linking isotretinoin (accutane), depression, psychosis, and suicide. Am J Ther 10 (2003) 148-159
7. Bruno N.P., Beacham B.E., and Burnett J.W. Adverse effects of isotretinoin therapy. Cutis 33 (1984) 484-486
8. Hull P.R., and Demkiw-Bartel C. Isotretinoin use in acne: prospective evaluation of adverse events. J Cutan Med Surg 4 (2000) 66-70
9. Serrano A., Rodriguez L., Linares M., et al. Isotretinoin and depression: a fact?. Acta Dermo Sifiliogr 94 (2003) 535-538
10. Kellett S.C., and Gawkrodger D.J. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 140 (1999) 273-282
11. Rubinow D.R., Peck G.L., Squillace K.M., et al. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 17 (1987) 25-32
12. Ferahbas A., Turan M.T., Esel E., et al. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin. J Dermatol Treat 15 (2004) 153-157
13. Ng C.H., Tam M.M., Celi E., et al. Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Austr J Dermatol 43 (2002) 262-268
14. Hersom K., Neary M.P., Levaux H.P., et al. Isotretinoin and antidepressant pharmacotherapy: A prescription sequence symmetry analysis. J Am Acad Dermatol 49 (2003) 424-432
15. Jick S.S., Kremers H.M., and Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 136 (2000) 1231-1236
16. Wysowski D., Pitts M., and Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 45 (2001) 515-519
17. Kessler R., McGonagle K., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51 (1994) 8-19
18. Beaudet M. Depression. Health Rep 7 (1996) 11-25
19. Alonso J., Angermeyer M., Bernert S., et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 420 (2004) 21-27
20. Waraich P., Goldner E., Somers J., et al. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 49 (2004) 124-138
21. Baldwin H.E. The interaction between acne vulgaris and the psyche. Cutis 70 (2002) 133-139
22. Gupta M.A., Gupta A.K., Schork N.J., et al. Psychiatric aspects of the treatment of mild to moderate facial acne: some preliminary observations. Int J Dermatol 29 (1990) 719-721
23. Yazici K., Baz K., Yazici A., et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol 18 (2004) 435-439
24. Gupta M., and Gupta A. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 139 (1998) 846-850
25. Niemeier V., Kupfer J., Demmelbauer-Ebner M., et al. Coping with acne vulgaris: evaluation of the Chronic Skin Disorder Questionnaire in patients with acne. Dermatology 196 (1998) 108-115
26. Newton J.N., Mallon E., Klassen A., et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 137 (1997) 563-567
27. Hull S.M., Cunliffe W.J., and Hughes B.R. Treatment of the depressed and dysmorphophobic acne patient. Clin Exp Dermatol 16 (1991) 210-211
28. Ng C.H., and Schweitzer I. The association between depression and isotretinoin use in acne. Aust N Z J Psychiatry 37 (2003) 78-84
29. Layton A.M., Seukeran D., and Cunliffe W.J. Scarred for life?. Dermatology 195 suppl 1 (1997) 15-21
30. Zimmerman M., Posternak M., and Chelminski I. Implications of using different cut-offs on symptom severity scales to define remission from depression. Int Clin Psychopharmacol 19 (2004) 215-220
31. Mulder R., Joyce P., and Frampton C. Relationships among measures of treatment outcome in depressed patients. J Affect Disord 76 (2003) 127-135
32. Svanborg P., and Asberg P. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS). J Affect Disord 64 (2001) 203-216
33. Orfanos C.E., and Zouboulis C.C. Oral retinoids in the treatment of seborrhea and acne. Dermatology 196 (1998) 140-147
34. Acne, isotretinoin and depression. Drug Ther Bull 41 (2003) 76-78
35. Petri H., Leufkens H., Naus J., et al. Rapid method for estimating the risk of acutely controversial side effects of prescription drugs. J Clin Epidemiol 43 (1990) 433-439
36. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 7 (1996) 478-484
37. Cher D. Myocardial infarction and acute cholecystitis: an application of sequence symmetry analysis. Epidemiology 11 (2000) 446-449
38. Kessler R.C., Avenevoli S., and Merikangas K.R. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry 49 (2001) 1002-1014
39. Culbertson F.M. Depression and gender. An international review. Am Psychol 52 (1997) 25-31
40. Davidson J., and Meltzer-Brody S. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?. J Clin Psychiatry 60 (1999) 4-9
41. Nierenberg A. Current perspectives on the diagnosis and treatment of major depressive disorder. Am J Manage Care 7 (2001) S353-S366
42. Wysowski D.K., and Jick S.S. Methodological limitations of the study "isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide.". " Arch Dermatol 137 (2001) 1102-1103
43. Kessler R., Borges G., and Walters E. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry 56 (1999) 617-626
44. Chaudron L., and Remington P. Age and gender differences in suicide trends, Wisconsin and the United States, 1980-1994. WMJ 98 (1999) 35-38
45. Weissman M., Bland R., Canino G., et al. Prevalence of suicidal ideation and suicide attempts in nine countries. Psychol Med 29 (1999) 9-17
46. Langlois S., and Morrison P. Suicide deaths and suicide attempts. Health Rep 13 (2002) 9-22
47. Hanson N., and Leachman S. Safety issues in isotretinoin therapy. Semin Cutan Med Surg 20 (2001) 166-183
48. Charakida A., Mouser P.E., and Chu A.C. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin Drug Saf 3 (2004) 119-129
49. Zigmond A., and Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
50. Beck A., Ward C., Mendelson M., et al. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
51. McNair D., and Lorr M. An analysis of mood in neurotics. J Abnorm Social Psychol 69 (1964) 620-627
52. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
53. Montgomery S., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389